L-carnitine Other names: Levocarnitine

Chemical formula: C₇H₁₅NO₃  Molecular mass: 161.199 g/mol  PubChem compound: 10917

Therapeutic indications

L-carnitine is indicated for:

Primary and secondary carnitine deficiency

Population group: only minors (0 - 18 years old) , adults (18 years old or older)

Carnitine deficiency

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Secondary L-carnitine deficiency in hemodialysis patients with end-stage renal failure

Population group: only minors (0 - 18 years old) , adults (18 years old or older)

Carnitine deficiency and additionally Hemodialysis procedure and additionally Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2018: LEVOCARNITINE PAEDIATRIC 30% Oral solution
Structured Product Labeling (SPL) 2021: CARNITOR Tablet / Oral solution
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈